ARRY-403, glucokinase activator; oral

DRUG2 trials

Sponsors

Array BioPharma, Array Biopharma, now a wholly owned subsidiary of Pfizer

Conditions

Type 2 Diabetes

Phase 1

A Safety Study of ARRY-403 in Patients With Type 2 Diabetes

CompletedNCT00859755

Array BioPharmaType 2 Diabetes

Start: 2009-03-31Updated: 2012-08-30

A Safety Study of ARRY-403 in Patients With Type 2 Diabetes

CompletedNCT00952198

Array Biopharma, now a wholly owned subsidiary of PfizerType 2 Diabetes

Start: 2009-08-31End: 2010-08-31Updated: 2020-10-06